Proprietary High Throughput Protocol™ (HTP™) Platform
Monoclonal antibodies delivered in 2 – 3 months
Our proprietary technology platform delivers the highest quality antibodies at industry leading speeds. Our HTP™ Mouse has been genetically engineered to produce a more sensitive immune response than mouse models. Due the broader epitope diversity of this response, it generates high affinity antibodies to the most traditionally difficult targets. We utilize a modified RIMMS protocol coupled with state-of-the-art automation to drastically reduce delivery timelines.
Each project workflow and screening methodology is custom designed to function in our customers’ final application. As part of our comprehensive antibody development services program, we also offer peptide design and synthesis. Using our PePro™ platform, our expert team of immunologists can design the best antigen for your project.
The HTP™ Protocol successfully generated antibodies to the following target types:
- Anti-idiotypic targets
- High homology targets (human, rat and even mouse proteins)
- 1-Amino acid specificity
- Small molecules
- Conformational specific epitopes
These hybridoma cell lines serve as reliable, long term antibody sources for many of our customers, who include industry leaders pharmaceutical, biotechnology as well as government agencies and academic institutions.
Traditional Antibody Development Program
Monoclonal antibodies delivered in 4 – 6 months
When speed is not a major consideration, we also offer an industry standard balb/c program at a discounted rate. Typical projects are delivered in 4-6 months, competitive with other traditional immunization programs in the marketplace.